Ryo Hanajiri

Nagoya, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

CD79A/CD40 intracellular domain uses a 4-1BB-like metabolic pathway driven by cholesterol biosynthesis.

CD79A/CD40 intracellular domain uses a 4-1BB-like metabolic pathway driven by cholesterol biosynthesis.

Journal: Journal for immunotherapy of cancer

Published: February 10, 2026

Drivers of temporal improvement in CAR T-cell therapy for large B-cell lymphoma: a Japanese nationwide registry analysis.

Drivers of temporal improvement in CAR T-cell therapy for large B-cell lymphoma: a Japanese nationwide registry analysis.

Journal: Blood advances

Published: December 24, 2025

BATF3 regulates differentiation of CD8+ T lymphocytes and memory differentiation program.

BATF3 regulates differentiation of CD8+ T lymphocytes and memory differentiation program.

Journal: Life science alliance

Published: October 27, 2025

Impact of CD5 expression on outcomes for chimeric antigen receptor-T cell therapy in relapsed and refractory diffuse large B-cell lymphoma.

Impact of CD5 expression on outcomes for chimeric antigen receptor-T cell therapy in relapsed and refractory diffuse large B-cell lymphoma.

Journal: Cytotherapy

Published: September 16, 2025

Disease status at CAR T-cell infusion in relapsed or refractory large B-cell lymphoma: prognostic significance for real-world outcomes, irrespective of bridging therapy.

Disease status at CAR T-cell infusion in relapsed or refractory large B-cell lymphoma: prognostic significance for real-world outcomes, irrespective of bridging therapy.

Journal: Bone marrow transplantation

Published: July 26, 2025

Percentage of CD56+ monocytes at neutrophil engraftment is associated with the incidence of acute graft-versus-host disease.

Percentage of CD56+ monocytes at neutrophil engraftment is associated with the incidence of acute graft-versus-host disease.

Journal: Annals of hematology

Published: July 01, 2025

Development and optimization of Eva1 (MPZL2) targeting chimeric antigen receptor T cells.

Development and optimization of Eva1 (MPZL2) targeting chimeric antigen receptor T cells.

Journal: Journal for immunotherapy of cancer

Published: April 16, 2025

Adjustment of low-dose ATG exposure improves outcomes in allogeneic hematopoietic stem cell transplantation: a prospective multicenter study.

Adjustment of low-dose ATG exposure improves outcomes in allogeneic hematopoietic stem cell transplantation: a prospective multicenter study.

Journal: Cytotherapy

Published: February 17, 2025

Robust CAR T-cell expansion and superior outcomes in DLBCL patients in complete response at infusion.

Robust CAR T-cell expansion and superior outcomes in DLBCL patients in complete response at infusion.

Journal: British journal of haematology

Published: January 31, 2025

Simple and early prediction of severe CAR-T-related adverse events after Axi-cel infusion by initial high fever.

Simple and early prediction of severe CAR-T-related adverse events after Axi-cel infusion by initial high fever.

Journal: International journal of hematology

Published: October 31, 2024

Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models.

Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models.

Journal: Molecular cancer therapeutics

Published: June 26, 2023

Manufacturing results of tisagenlecleucel for acute lymphoblastic leukemia: a survey by the CAR-T cell therapy taskforce of the Japan Society of Transfusion Medicine and Cell Therapy

Manufacturing results of tisagenlecleucel for acute lymphoblastic leukemia: a survey by the CAR-T cell therapy taskforce of the Japan Society of Transfusion Medicine and Cell Therapy

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: June 04, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026